Prostate cancer‐secreted
CCN3
uses the
GSK3β
and β‐catenin pathways to enhance osteogenic factor levels in osteoblasts
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):